Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis.

G. Vescovo, F. Serafini, L. Facchin, P. Tenderini, U. Carraro, L. Dalla Libera, C. Catani, G. B. Ambrosio

Department of Internal Medicine I, Venice City Hospital, Italy.

OBJECTIVE: In congestive heart failure (CHF) the skeletal muscle of the lower limbs develops a myopathy with atrophy and shift from the slow type to the fast type fibres. The aim was to test the hypothesis that this myopathy is specific and not simply related to detraining, by comparing patients with different degrees of CHF with patients with severe muscle atrophy due to disuse. DESIGN: Case-control study involving 50-150 micrograms needle biopsies of the gastrocnemius muscle. By an electrophoretic micromethod, the three isoforms of myosin heavy chains (MHC) were separated. PATIENTS: Five patients restricted to bed for more than one year because of stroke with disuse atrophy and normal ventricular function, and 19 with CHF were studied. There were seven age matched controls. MAIN OUTCOME MEASURES: The percentage of MHC1 (slow isoform), MHC2a (fast oxidative), and MHC2b (fast glycolytic) was determined by densitometric scan and correlated with indices of severity of cardiac failure. RESULTS: Ejection fraction was 42.5 (SD 15.2)% in CHF, 59.5 (1.0)% in disuse atrophy and 60.3 (1.4)% in controls (P < 0.001 v both). The degree of muscle atrophy as calculated by the body mass index/gastrocnemius cross sectional area, showed a profound degree of atrophy in patients with muscle disuse [0.94 (0.39)]. This was worse than in the controls [4.27 (0.16), P < 0.0005] and the CHF patients [2.60 (1.10), P < 0.005]. Atrophy in CHF patients was also greater than in controls (P < 0.005). MHC1 was lower in CHF than in disuse atrophy [51.83 (15.04) v 84.5 (17.04), P < 0.01] while MHC2b was higher [23.5 (7.4) v 7.25 (7.92), P < 0.001]. There was a similar trend for MHC2a [24.83 (15.01) v 8.25 (9.12), P < 0.05]. Within the CHF group there was a positive correlation between NYHA class and MHC2a (r = 0.47, P < 0.05) and MHC2b (r = 0.55, P < 0.01) and a negative correlation between NYHA class and MHC1 (r = -0.74, P < 0.001). Similarly, significant correlations were found for ejection fraction, diuretic consumption score, exercise test tolerance, and degree of muscle atrophy. CONCLUSIONS: The CHF myopathy appears to be specific and not related to detraining. The magnitude of MCH redistribution correlates with the severity of the disease. The electrophoretic micromethod used is very sensitive and reproducible. Biopsies are so well tolerated that can be repeated frequently, allowing thorough follow up.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Miller, M. S., VanBuren, P., LeWinter, M. M., Lecker, S. H., Selby, D. E., Palmer, B. M., Maughan, D. W., Ades, P. A., Toth, M. J. (2009). Mechanisms Underlying Skeletal Muscle Weakness in Human Heart Failure: Alterations in Single Fiber Myosin Protein Content and Function. Circ Heart Fail 2: 700-706 [Abstract] [Full Text]  
• Okada, Y., Toth, M. J., VanBuren, P. (2008). Skeletal muscle contractile protein function is preserved in human heart failure. J. Appl. Physiol. 104: 952-957 [Abstract] [Full Text]  
• Toth, M. J., Ades, P. A., LeWinter, M. M., Tracy, R. P., Tchernof, A. (2006). Skeletal muscle myofibrillar mRNA expression in heart failure: relationship to local and circulating hormones. J. Appl. Physiol. 100: 35-41 [Abstract] [Full Text]  
• Vescovo, G., Ravara, B., Gobbo, V., Libera, L. D. (2005). Inflammation and perturbation of the L-carnitine system in heart failure. Eur J Heart Fail 7: 997-1002 [Abstract] [Full Text]  
• Toth, M. J., Matthews, D. E., Ades, P. A., Tischler, M. D., Van Buren, P., Previs, M., LeWinter, M. M. (2005). Skeletal muscle myofibrillar protein metabolism in heart failure: relationship to immune activation and functional capacity. Am. J. Physiol. Endocrinol. Metab. 288: E685-E692 [Abstract] [Full Text]  
• Hayot, M., Michaud, A., Koechlin, C., Caron, M-A., LeBlanc, P., Prefaut, C., Maltais, F. (2005). Skeletal muscle microbiopsy: a validation study of a minimally invasive technique. Eur Respir J 25: 431-440 [Abstract] [Full Text]  
• Vescovo, G., Ravara, B., Gobbo, V., Sandri, M., Angelini, A., Della Barbera, M., Dona, M., Peluso, G., Calvani, M., Mosconi, L., Dalla Libera, L. (2002). L-Carnitine: a potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure. Am. J. Physiol. Cell Physiol. 283: C802-C810 [Abstract] [Full Text]  
• Duscha, B. D., Annex, B. H., Green, H. J., Pippen, A. M., Kraus, W. E. (2002). Deconditioning fails to explain peripheral skeletal muscle alterations in men with chronic heart failure. J Am Coll Cardiol 39: 1170-1174 [Abstract] [Full Text]  
• Coats, A. J S (2001). HEART FAILURE: What causes the symptoms of heart failure?. Heart 86: 574-578 [Full Text]  
• Aschenbach, W. G., Brower, G. L., Talmadge, R. J., Dobson, J. L., Gladden, L. B. (2001). Effect of a myocardial volume overload on lactate transport in skeletal muscle sarcolemmal vesicles. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281: R176-R186 [Abstract] [Full Text]  
• Pu, C. T., Johnson, M. T., Forman, D. E., Hausdorff, J. M., Roubenoff, R., Foldvari, M., Fielding, R. A., Singh, M. A. F. (2001). Randomized trial of progressive resistance training to counteract the myopathy of chronic heart failure. J. Appl. Physiol. 90: 2341-2350 [Abstract] [Full Text]  
• Dalla Libera, L., Ravara, B., Angelini, A., Rossini, K., Sandri, M., Thiene, G., Battista Ambrosio, G., Vescovo, G. (2001). Beneficial Effects on Skeletal Muscle of the Angiotensin II Type 1 Receptor Blocker Irbesartan in Experimental Heart Failure. Circulation 103: 2195-2200 [Abstract] [Full Text]  
• Dorigo, P., Floreani, M., Santostasi, G., Maragno, I., Danieli-Betto, D., Germinario, E., Magno, S. M., Primofiore, G., Marini, A. M., Da Settimo, F. (2000). Pharmacological Characterization of a New Ca2+ Sensitizer. J. Pharmacol. Exp. Ther. 295: 994-1004 [Abstract] [Full Text]  
• Sutaria, N, Northridge, D B, Shaw, T R D (2000). Significance of commissural calcification on outcome of mitral balloon valvotomy. Heart 84: 398-402 [Abstract] [Full Text]  
• Vescovo, G, Volterrani, M, Zennaro, R, Sandri, M, Ceconi, C, Lorusso, R, Ferrari, R, Ambrosio, G B, Dalla Libera, L (2000). Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes. Heart 84: 431-437 [Abstract] [Full Text]  
• dalla Libera, L., Zennaro, R., Sandri, M., Ambrosio, G. B., Vescovo, G. (1999). Apoptosis and atrophy in rat slow skeletal muscles in chronic heart failure. Am. J. Physiol. Cell Physiol. 277: C982-C986 [Abstract] [Full Text]  
• Opasich, C., Ambrosino, N., Felicetti, G., Aquilani, R., Pasini, E., Bergitto, D., Mazza, A., Cobelli, F., Tavazzi, L. (1999). Heart failure-related myopathy. Clinical and pathophysiological insights. Eur Heart J 20: 1191-1200 [Abstract]  
• Anker, S.D., Ponikowski, P.P., Clark, A.L., Leyva, F., Rauchhaus, M., Kemp, M., Teixeira, M.M., Hellewell, P.G., Hooper, J., Poole-Wilson, P.A., Coats, A.J.S. (1999). Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J 20: 683-693 [Abstract]  
• Anker, S. D., Coats, A. J. S. (1999). Cardiac Cachexia: A Syndrome With Impaired Survival and Immune and Neuroendocrine Activation. Chest 115: 836-847 [Abstract] [Full Text]  
• Vescovo, G., Dalla Libera, L., Serafini, F., Leprotti, C., Facchin, L., Volterrani, M., Ceconi, C., Ambrosio, G. B. (1998). Improved Exercise Tolerance After Losartan and Enalapril in Heart Failure : Correlation With Changes in Skeletal Muscle Myosin Heavy Chain Composition. Circulation 98: 1742-1749 [Abstract] [Full Text]  
• Vescovo, G., Ceconi, C., Bernocchi, P., Ferrari, R., Carraro, U., Ambrosio, G. B., Dalla Libera, L. (1998). Skeletal muscle myosin heavy chain expression in rats with monocrotaline-induced cardiac hypertrophy and failure. Relation to blood flow and degree of muscle atrophy. Cardiovasc Res 39: 233-241 [Abstract] [Full Text]  
• Anker, S. D., Chua, T. P., Ponikowski, P., Harrington, D., Swan, J. W., Kox, W. J., Poole-Wilson, P. A., Coats, A. J. S. (1997). Hormonal Changes and Catabolic/Anabolic Imbalance in Chronic Heart Failure and Their Importance for Cardiac Cachexia. Circulation 96: 526-534 [Abstract] [Full Text]